{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:18:51Z","timestamp":1762075131033,"version":"build-2065373602"},"reference-count":31,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background: Drug addiction may play an important role in chronic migraine (CM) with medication-overuse headache (MOH). Psychiatric diseases are associated with CM, but data regarding obsessive\u2013compulsive disorder (OCD) are lacking. We aimed to establish the prevalence of OCD traits in CM patients with MOH and the impact on onabotulinum toxin A (OBT-A) treatment. Methods: A total of 75 patients with CM and MOH undergoing treatment with OBT-A in our Headache Centre were evaluated. At baseline and after four injection sessions, we assessed the migraine burden and the presence of OCD traits with the Obsessive\u2013Compulsive Inventory\u2014Revised (OCI-R) test. Results: At baseline, 28% of patients had OCI-R scores compatible with borderline OCD aspects, while 22.7% were pathological. An improvement in headache was significantly associated with an increase in the number of subjects with a normal OCI-R score at T0 and T1, whereas patients with a pathological OCI-R score at T0 showed a significantly higher prevalence of CM at T1. Conclusions: Our data showed a significant rate of OCD traits at baseline, which could strengthen the hypothesis of an addictive disorder underlying CM with MOH. OCD traits seem to influence the OBT-A response. An OCD assessment could be useful in improving patients\u2019 selections before starting treatments.<\/jats:p>","DOI":"10.3390\/brainsci12111563","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T03:31:10Z","timestamp":1668742270000},"page":"1563","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Onabotulinum Toxin A on Obsessive\u2013Compulsive Traits in a Population of Chronic Migraine Patients"],"prefix":"10.3390","volume":"12","author":[{"given":"Giovanna","family":"Viticchi","sequence":"first","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, 60020 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3411-2388","authenticated-orcid":false,"given":"Lorenzo","family":"Falsetti","sequence":"additional","affiliation":[{"name":"Internal and Subintensive Medicine, Ospedali Riuniti, 60020 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Salvemini","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, 60020 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Bartolini","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, 60020 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Paolucci","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, 60020 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Buratti","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, 60020 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-7388","authenticated-orcid":false,"given":"Mauro","family":"Silvestrini","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, 60020 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/13697137.2018.1439914","article-title":"Migraine, hormones and the menopausal transition","volume":"21","author":"Gompel","year":"2018","journal-title":"Climacteric"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10072-019-03886-4","article-title":"Influence of chronotype on migraine characteristics","volume":"40","author":"Viticchi","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13760-021-01637-x","article-title":"Headache changes after kidney transplant","volume":"122","author":"Viticchi","year":"2022","journal-title":"Acta Neurol. Belg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10194-009-0134-2","article-title":"Psychiatric comorbidity in patients with chronic daily headache and migraine: A selective overview including personality traits and suicide risk","volume":"10","author":"Pompili","year":"2009","journal-title":"J. Headache Pain"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00415-012-6725-x","article-title":"Psychiatric comorbidities of episodic and chronic migraine","volume":"260","author":"Buse","year":"2013","journal-title":"J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10194-010-0282-4","article-title":"Migraine and psychiatric comorbidity: A review of clinical findings","volume":"12","author":"Antonaci","year":"2011","journal-title":"J. Headache Pain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.0b013e3181974b19","article-title":"Tracing transformation: Chronic migraine classification, progression, and epidemiology","volume":"72","author":"Lipton","year":"2009","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1526-4610.2009.01457.x","article-title":"Obsessive-compulsive disorder and migraine with medication-overuse headache","volume":"49","author":"Cupini","year":"2009","journal-title":"Headache"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0333102410378051","article-title":"Post-traumatic stress disorder, drug abuse and migraine: New findings from the National Comorbidity Survey Replication (NCS-R)","volume":"31","author":"Peterlin","year":"2011","journal-title":"Cephalalgia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10194-010-0187-2","article-title":"Headache, anxiety and depressive disorders: The HADAS study","volume":"11","author":"Beghi","year":"2010","journal-title":"J. Headache Pain"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1007\/s10072-011-0527-2","article-title":"Psychopathological profile of patients with chronic migraine and medication overuse: Study and findings in 50 cases","volume":"32","author":"Curone","year":"2011","journal-title":"Neurol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10072-014-1767-8","article-title":"Prevalence and profile of obsessive-compulsive trait in patients with chronic migraine and medication overuse","volume":"35","author":"Curone","year":"2014","journal-title":"Neurol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1007\/s10072-012-1070-5","article-title":"Obsessive\u2013compulsive aspects as predictors of poor response to treatments in patients with chronic migraine and medication overuse","volume":"33","author":"Curone","year":"2012","journal-title":"Neurol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s10194-021-01333-4","article-title":"Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: Data from an open label long-term prospective study","volume":"22","author":"Bottiroli","year":"2021","journal-title":"J. Headache Pain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1177\/1090820X12474629","article-title":"A review of onabotulinumtoxinA (Botox)","volume":"33","author":"Lorenc","year":"2013","journal-title":"Aesthet. Surg. J."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38, 1\u2013211.","DOI":"10.1177\/0333102417738202"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.janxdis.2008.07.001","article-title":"The Italian version of Obsessive Compulsive Inventory: Its psychometric properties on community and clinical samples","volume":"23","author":"Sica","year":"2009","journal-title":"J. Anxiety Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14737175.2018.1419867","article-title":"Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life","volume":"18","author":"Tassorelli","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10072-020-04661-6","article-title":"Migraineurs\u2019 psychological traits do not influence response to erenumab","volume":"41","author":"Altamura","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1526-4610.2010.01755.x","article-title":"What is the role of dependence-related behavior in medication-overuse headache?","volume":"50","author":"Radat","year":"2010","journal-title":"Headache"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ejp.1715","article-title":"Dependence-like behaviour in patients treated for medication overuse headache: A prospective open-label randomized controlled trial","volume":"25","author":"Rouw","year":"2021","journal-title":"Eur. J. Pain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1526-4610.2007.00999.x","article-title":"Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria","volume":"48","author":"Radat","year":"2008","journal-title":"Headache"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/archpsyc.63.11.1225","article-title":"Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder","volume":"63","author":"Remijnse","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/brain\/awh691","article-title":"Orbito-frontal cortex involvement in chronic analgesic- overuse headache evolving from episodic migraine","volume":"129","author":"Fumal","year":"2006","journal-title":"Brain"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/bs.pbr.2020.05.019","article-title":"Clinical and biobehavioral perspectives: Is medication overuse headache a behavior of dependence?","volume":"255","author":"Lau","year":"2020","journal-title":"Prog. Brain Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pnpbp.2018.01.010","article-title":"The role of the orbitofrontal cortex in alcohol use, abuse, and dependence","volume":"87","author":"Moorman","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s10194-018-0840-8","article-title":"Long-term study of the efficacy and safety of onabotulinumtoxinA for the prevention of chronic migraine: COMPEL study","volume":"19","author":"Blumenfeld","year":"2018","journal-title":"J. Headache Pain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpsychires.2021.01.016","article-title":"Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis","volume":"135","author":"Schulze","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2018-319290","article-title":"Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety","volume":"90","author":"Blumenfeld","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.neuroimage.2012.01.117","article-title":"Resting state functional connectivity in addiction: Lessons learned and a road ahead","volume":"62","author":"Sutherland","year":"2012","journal-title":"Neuroimage"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/12\/11\/1563\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:20:20Z","timestamp":1760145620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/12\/11\/1563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["brainsci12111563"],"URL":"https:\/\/doi.org\/10.3390\/brainsci12111563","relation":{},"ISSN":["2076-3425"],"issn-type":[{"type":"electronic","value":"2076-3425"}],"subject":[],"published":{"date-parts":[[2022,11,17]]}}}